Asia-Pacific Capnography Equipment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Capnography Accessories & Disposables and Capnometers), Technology (Mainstream Capnography, Sidestream Capnography, and Microstream Capnography), Application (Cardiac Care, Trauma and Emergency Care, Procedural Sedation, Respiratory Monitoring, and Other Applications), and End User (Hospitals, Ambulatory Surgical Center, Home Care Settings, and Others)
The capnography equipment market in APAC is expected to grow from US$ 98.35 million in 2022 to US$ 150.94 million by 2028. It is estimated to grow at a CAGR of 7.4% from 2022 to 2028.
Advancements in Handheld Capnography Equipment Drive Capnography Equipment Market in APAC
Existing CO2 measurement devices, including arterialized capillary blood gas, arterial blood gas, and venous blood gas analysis devices, are considered a gold standard in clinical practices. However, these devices are invasive and require the recurrent collection of blood samples for CO2 measurement, which may cause pain and discomfort among patients and unexpected blood loss. Moreover, these are time-consuming procedures that specifically require expertise and skills. As the conventional CO2 measuring techniques can go on for a long span, they inflict damage to tissue, nerves, and vessels. In contrast, handheld capnography instruments are easier to use than their conventional counterparts, and they can also be used in home care settings. Therefore, key companies are focused on developing portable/point-of-care or handheld capnography equipment for use in applications that require easy device mobility and patient access. Capnocheck II Hand-Held Capnograph/Oximeter/CO2 Detector by Smiths Group Plc, Microcap Handheld Capnographs by Medtronic Plc, and EMMA Capnograph and EMMA Mainstream Capnometer by Masimo Corporation are a few examples of handheld capnography equipment available in the market.
Market Overview
Asia Pacific (APAC) is the fastest-growing regional market for capnography equipment. The capnography equipment market in Asia Pacific is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. The region accounted for 8.1% share of the global market in 2021. The rising prevalence of benign prostatic hyperplasia amongst men along with increasing risk factors, surging demand for minimally invasive treatment in the region, and the growing prevalence of obesity in the region propel the Asia Pacific capnography equipment market growth. China dominated the regional market. The capnography equipment market in China is expected to expand during the forecast period owing to the increasing prevalence of COPD in the country and the surging number of surgeries. For instance, according to the data published in Journal of Thoracic Diseases in China, COPD is increasingly becoming a cause of public health concern and ranks first among the causes of disability. Moreover, in 2018, the overall prevalence rate of COPD in China is 8.2% and mortality rate because of the disease is ~1.6%. COPD is reported to be the fourth leading cause of death in rural areas, with a prevalence rate of 4.4% to 16.7%. Therefore, the growing prevalence of COPD is fueling the growth of the capnography market in China.
APAC Capnography Equipment Market Revenue and Forecast to 2028 (US$ Million)
APAC Capnography Equipment Market Segmentation
The APAC capnography equipment market is segmented into product type, technology, application, end user and country. Based on product type, the market is segmented into capnometer and capnography accessories & disposables. The capnography accessories & disposables segment registered a larger market share in 2022.
Based on technology, the APAC capnography equipment market is segmented into mainstream capnography, sidestream capnography, and microstream capnography. The mainstream capnography segment registered the largest market share in 2022. Based on application, the APAC capnography equipment market is segmented into cardiac care, trauma and emergency care, procedural sedation, respiratory monitoring, and others. The cardiac care segment registered the largest market share in 2022. Based on end user, the APAC capnography equipment market is segmented into hospitals, ambulatory surgery center, home care settings, and others. The hospitals segment registered the largest market share in 2022. Based on country, the APAC capnography equipment market is segmented into Australia, China, India, Japan, South Korea, and the Rest of APAC. China dominated the market share in 2022. BD, Dragerwerk AG & Co. KGaA, General Electric Company, Hill Rom Holding Inc. (Baxter), ICU Medical Inc., Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, and SCHILLER Americas Inc. are among the leading companies operating in the capnography equipment market in the region.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC capnography equipment market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC capnography equipment market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the capnography equipment market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook